D-741-2014 Class III Terminated
FDA drug recall D-741-2014 was initiated by Novartis Consumer Health on May 15, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 167,712/24-caplet packages.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2014
- Initiation Date
- May 15, 2013
- Termination Date
- Nov 4, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 167,712/24-caplet packages
Product description
Maximum Strength Comtrex ,Severe Cold & Sinus Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Phenylephrine HCL 5mg, packaged in 12 coated caplets daytime formula and 12 coated caplets nighttime formula. Novartis, distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2081-24
Reason for recall
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.
Distribution pattern
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Code information
Lot# 10117247 06/13 Lot# 10119336 07/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-741-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026